Haloperidol is an antipsychotic drug commonly used to treat a range of neurological disorders, including schizophrenia, Tourette syndrome, bipolar disorder and others. The drug works by blocking ...

This transcript has been edited for clarity. John Kane, MD: Hi. I'm Dr John Kane, professor of psychiatry at The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in New York. Welcome ...

The US Food and Drug Administration (FDA) is due to issue a decision by September 26 on the approval of KarXT, a potential first-in-class antipsychotic. If approved, it would be the first drug with a ...

In a previous article, I made the case that little has changed within the antipsychotic drug landscape over the past 70 years since the only effective medications for the treatment of schizophrenia ...

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach. By Ellen Barry and Christina Jewett The Food and Drug Administration on ...

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...

In its first Phase Three clinical test, an experimental antipsychotic medicine called lumateperone has shown evidence of being both effective and safe. That is the conclusion of a research team that ...

Scientists with UT Southwestern's Peter O'Donnell Jr. Brain Institute have identified the molecular mechanism that can cause weight gain for those using a common antipsychotic medication. The findings ...

A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Md. automation The U.S. Food and Drug Administration (FDA) on Thursday approved the first ...